Latest / The Steve Harvey Morning Show / Entrepreneur: He's making it easier for people with Opioid Use Disorder to commit to their methadone treatment program.

Transcript

Entrepreneur: He's making it easier for people with Opioid Use Disorder to commit to their methadone treatment program. · The Steve Harvey Morning Show

• 0:05
  Speaker 1: Welcome to the show.
• 0:06
  Speaker 2: I am Rashan McDonald, the host of Money Making Conversations Masterclass,
• 0:10
  Speaker 2: where we encourage people to stop reading other people's success
• 0:13
  Speaker 2: stories and start planning their own. Listen up as I
• 0:17
  Speaker 2: interview entrepreneurs from around the country, talk to celebrities and
• 0:21
  Speaker 2: ask them how they are running their companies, and speak
• 0:24
  Speaker 2: with dog profits who are making a difference in their
• 0:26
  Speaker 2: local communities. Now, sit back and listen as we unlock
• 0:29
  Speaker 2: the secrets to their success on Money Making Conversations Masterclass. Welcome, Welcome,
• 0:37
  Speaker 2: It's another day the time for Money Making Conversation Masterclass.
• 0:41
  Speaker 2: I am the host of the show, Rashan McDonald. I
• 0:43
  Speaker 2: created it in twenty seventeen. It's an idea to be
• 0:46
  Speaker 2: able to marry information that successful entrepreneurs in the working
• 0:51
  Speaker 2: platforms can share their success stories or their stories of optimism,
• 0:55
  Speaker 2: their stories of the moments when they think it was
• 0:58
  Speaker 2: all going to go bad and how they turn to
• 1:00
  Speaker 2: write at the ship. And that's what Money Making Conversations
• 1:02
  Speaker 2: Masters I do. Have celebrities who come on the show
• 1:05
  Speaker 2: who have an entrepreneurial I and they can share their
• 1:08
  Speaker 2: stories because we're all in the same boat. That's to
• 1:11
  Speaker 2: be successful to employ people, pay our taxes on time,
• 1:15
  Speaker 2: and also create generational wealth. That is what money Making
• 1:18
  Speaker 2: Conversations Masterclass is all about. The interviews and information that
• 1:22
  Speaker 2: this show provides really is for everyone. It's time to
• 1:25
  Speaker 2: stop reading other people's success stories and start living your own.
• 1:29
  Speaker 3: Now.
• 1:29
  Speaker 2: If you want to be a guest on my show,
• 1:31
  Speaker 2: please visit Moneymakingconversations dot com. That's Moneymakingconversations dot com and
• 1:37
  Speaker 2: click to be a guest button. You submit the information
• 1:40
  Speaker 2: who you are infyting in the background, and then I
• 1:43
  Speaker 2: contact you if you submit all the right information to
• 1:46
  Speaker 2: be a guest on my show. Now let's get to
• 1:48
  Speaker 2: show rolling. It's a different show because we're talking about
• 1:52
  Speaker 2: the world of people who are impacted by what's going
• 1:55
  Speaker 2: on and sometimes can't control their own narrative their organizations.
• 1:58
  Speaker 2: There are businesses out there they're helping people write the
• 2:02
  Speaker 2: ship my guests on the show today makes it easier
• 2:05
  Speaker 2: for people with opr use disorder that's oud to commit
• 2:09
  Speaker 2: to their methadone treatment program. He has witnessed the devastating
• 2:13
  Speaker 2: impact of opr use disorder on individuals, families, and their communities.
• 2:18
  Speaker 2: Please welcome to the Money Making Conversations Masterclass, Doctor Michael Giles.
• 2:22
  Speaker 1: How you doing, sir, I'm doing well.
• 2:24
  Speaker 4: Thanks for having me.
• 2:25
  Speaker 1: Rashan, I know, but a pridor to the interview.
• 2:27
  Speaker 2: I called Michael because of the serious nature and I
• 2:31
  Speaker 2: don't want people to turn off because it's serves is dark.
• 2:33
  Speaker 1: Now, this is life.
• 2:34
  Speaker 2: This is about people who are trying to get on
• 2:38
  Speaker 2: with their lives that have been impacted by a drug
• 2:40
  Speaker 2: that's been devastating this country for a number of years now.
• 2:44
  Speaker 2: You've seen a lot of news stories out there where
• 2:47
  Speaker 2: larger companies have been sued and judgments have been worn
• 2:50
  Speaker 2: against them, and communities, not just individuals, but communities and
• 2:54
  Speaker 2: have been destroyed by this drug OPR drug. Well, people
• 2:59
  Speaker 2: want to get on with their lives and sometimes this
• 3:01
  Speaker 2: drug won't allow All the treatment technique that's being offered
• 3:05
  Speaker 2: to them won't allow them to get on with their lives.
• 3:08
  Speaker 2: So I invited Michael on the show to talk about it.
• 3:11
  Speaker 2: Gives a little backround about you before we get started
• 3:13
  Speaker 2: at Michael Sure.
• 3:15
  Speaker 4: So, I'm a psychiatrist and I started a company called
• 3:19
  Speaker 4: Scenario Health during the last year of my psychiatry training
• 3:25
  Speaker 4: based on my experience working in an Opioid Treatment Program,
• 3:28
  Speaker 4: which is the only facility in the United States where
• 3:31
  Speaker 4: you can receive methadone. So there's about two thousand of
• 3:34
  Speaker 4: these OTPs across the United States, and the standard of
• 3:38
  Speaker 4: cares for patients to drive to this clinic every day
• 3:42
  Speaker 4: for an initial period of time, wait in line, and
• 3:45
  Speaker 4: then take a dose of the medication methadone in front
• 3:49
  Speaker 4: of a care provider. Right, And this requirement for daily
• 3:54
  Speaker 4: visits is really strenuous for patients who have jobs, or
• 3:58
  Speaker 4: are an education or have kids to take care of.
• 4:03
  Speaker 4: And you know, I would, you know, when I was
• 4:05
  Speaker 4: on this rotation, I would advocate these patients to get
• 4:08
  Speaker 4: take home methodones so they wouldn't have to come in
• 4:09
  Speaker 4: every day. And the provider often didn't trust the patient.
• 4:13
  Speaker 4: It seemed like if someone built a tool that gave
• 4:17
  Speaker 4: patients the opportunity to demonstrate how they're using the medication
• 4:20
  Speaker 4: at home, that these patients could then get take home
• 4:24
  Speaker 4: methodone instead of having to come into the clinic every day.
• 4:27
  Speaker 4: And so that's exactly what our application was designed to do.
• 4:32
  Speaker 4: We launched at the end.
• 4:33
  Speaker 2: Oh, before we get too far into the whole process,
• 4:35
  Speaker 2: because there are steps to that, like you ever said
• 4:37
  Speaker 2: the doctor did trust the patient. Now we've got to
• 4:40
  Speaker 2: talk about the idea of you creating this concept and
• 4:44
  Speaker 2: then implementing the concept or against a beta period, and
• 4:48
  Speaker 2: then being able to implement it for doctors to trust you.
• 4:51
  Speaker 2: So when did you first implement the concept as a
• 4:54
  Speaker 2: band of possibility, Because, like you said, you've seen this
• 4:57
  Speaker 2: drug devastates the community.
• 4:58
  Speaker 1: You've seen this drug.
• 4:59
  Speaker 2: And and and the way it was being the methadone
• 5:03
  Speaker 2: was being applied. They had to come up here every day,
• 5:05
  Speaker 2: like you said, disrupt their life. When did this idea
• 5:07
  Speaker 2: pop in your head?
• 5:09
  Speaker 4: What happened on during my residency I was training, I
• 5:14
  Speaker 4: was I was just talking to the attending positions, like
• 5:17
  Speaker 4: the boss docker and I was asking and like, you know,
• 5:19
  Speaker 4: what would it take for these patients to like get
• 5:23
  Speaker 4: some take on methadone? And you know, the attending position
• 5:27
  Speaker 4: the response would be, if I understood how they're using
• 5:29
  Speaker 4: their medication, I would be more comfortable giving them, you know,
• 5:32
  Speaker 4: multiple doses so they don't have to come in every day.
• 5:35
  Speaker 4: So kind of the business concept was designed to solve
• 5:39
  Speaker 4: a specific problem, right, and it's a problem of patient
• 5:43
  Speaker 4: provider trust. It's really what our product does solve.
• 5:46
  Speaker 2: So when you when you talk about this, you know,
• 5:48
  Speaker 2: because it's all about trust, because like I said, the
• 5:50
  Speaker 2: doctors see there as a remedy, but they have no
• 5:54
  Speaker 2: they have no solution. And so when you started sitting down,
• 5:59
  Speaker 2: did you sit down with family them is said, I
• 6:00
  Speaker 2: was a friends and I would investors to start building
• 6:04
  Speaker 2: this concept out. And because everything is is a great concept,
• 6:08
  Speaker 2: but it also has to be as they say, profitable.
• 6:10
  Speaker 2: One has to be able to make money if you
• 6:12
  Speaker 2: have to continue. So break down the whole process of
• 6:15
  Speaker 2: you know, when you started, okay, this is reality, you
• 6:18
  Speaker 2: know this can actually happen. Did you go to someone
• 6:21
  Speaker 2: in the medical field for advice? What did you do?
• 6:26
  Speaker 4: It's interesting there was a lot of networking, right, Yeah.
• 6:30
  Speaker 4: The question you're asking is really important, like how do
• 6:33
  Speaker 4: I know that this is a problem that like is
• 6:37
  Speaker 4: worth solving, Like are there people who actually use the product?
• 6:41
  Speaker 4: And so I actually reached out to the private equity
• 6:45
  Speaker 4: group that owned one of the largest OTPs in the
• 6:49
  Speaker 4: United States, and I sleep kind of shared my presentation
• 6:55
  Speaker 4: on like what my vision for our product would be,
• 6:58
  Speaker 4: and this private ecta group is actually really interested, and
• 7:00
  Speaker 4: so they introduced me to the CEO of one of
• 7:03
  Speaker 4: these large OPO trument program companies, and you know, I
• 7:07
  Speaker 4: think the way to that introduction coming from the private
• 7:10
  Speaker 4: equity group. Let them take what I was saying more seriously.
• 7:14
  Speaker 4: And the fact that I was maybe position also helped
• 7:17
  Speaker 4: add some credibility. And so yeah, when I shared kind
• 7:21
  Speaker 4: of the concept with the executive leadership at this OPR
• 7:24
  Speaker 4: trutment program, they were hesitant, but overall like pretty supportive
• 7:29
  Speaker 4: and they said, yeah, we would love to test something
• 7:31
  Speaker 4: like this out.
• 7:33
  Speaker 2: So yeah, so, as we all know, the word in
• 7:36
  Speaker 2: the test period is called the beta period.
• 7:38
  Speaker 1: When you know, you.
• 7:39
  Speaker 2: Go out there, you making sure there are no bugs
• 7:41
  Speaker 2: in the process and there are no bad apples in
• 7:45
  Speaker 2: the process. Now when you when you started choosing you know,
• 7:50
  Speaker 2: potential patients for this process and explain everybody to the
• 7:55
  Speaker 2: process right now.
• 7:58
  Speaker 4: Oh so, we before we launched a full product, we
• 8:02
  Speaker 4: did have kind of like a test version, and like
• 8:06
  Speaker 4: we got funding from the National Institute of Health to
• 8:11
  Speaker 4: pilot our test version. And one of the pilot sites,
• 8:15
  Speaker 4: like the very first site was in the Tenderline district
• 8:18
  Speaker 4: of San Francisco, and that's kind of like ground zero,
• 8:23
  Speaker 4: like if you really want to find out if your
• 8:25
  Speaker 4: application works, go like, you know, to help obi used
• 8:28
  Speaker 4: disorder test it out there.
• 8:30
  Speaker 1: Wow.
• 8:30
  Speaker 2: So I was why why do you say that? I'm
• 8:32
  Speaker 2: just asking why? Why is it because of overorder? Because
• 8:36
  Speaker 2: it's Silicon Valley with apps and everything's out there and
• 8:38
  Speaker 2: technologies are such a high level.
• 8:41
  Speaker 4: Yeah, because the first thing, the burden of like, ohgl
• 8:45
  Speaker 4: use disorder is very high, specifically like in San Francisco,
• 8:50
  Speaker 4: but even more so like in the Tenderline district. You know,
• 8:55
  Speaker 4: like walking to clinic from the subway, you will see
• 8:59
  Speaker 4: people use seeing drugs outside's a clinic, you will see
• 9:02
  Speaker 4: people who are in a state of overdose. It's like
• 9:05
  Speaker 4: it's pretty terrifying. And I was like, man, why are
• 9:08
  Speaker 4: we launching here? This is like like if this is
• 9:12
  Speaker 4: like these patients seem so unstable, like how are they
• 9:14
  Speaker 4: going to use this application? And I learned something then,
• 9:18
  Speaker 4: because these patients shattered my expectations. All they needed was
• 9:22
  Speaker 4: just a little bit of something to prove themselves. And
• 9:25
  Speaker 4: so that's the.
• 9:27
  Speaker 2: Story of when the me ask you this, doctor Giles,
• 9:29
  Speaker 2: because I would tell you something from a stereo type
• 9:34
  Speaker 2: San Francisco wouldn't be the place I would think you
• 9:36
  Speaker 2: would find a high concentration because I'm thinking San Franciscos, liberal,
• 9:41
  Speaker 2: very highly educated community. These are the things that run
• 9:44
  Speaker 2: through my mind. I'm thinking maybe, uh, West Virginia. I'm
• 9:48
  Speaker 2: thinking maybe Kentucky. I'm thinking rural areas will probably be
• 9:52
  Speaker 2: high volume usage area. And you're telling me novershan, San Francisco.
• 9:56
  Speaker 2: Why do I have this stereo type about people who
• 10:00
  Speaker 2: use opiods.
• 10:01
  Speaker 1: In my head?
• 10:03
  Speaker 4: Well, the areas you mentioned are kind of where the
• 10:08
  Speaker 4: epidemics started, so I don't know, maybe there's like a
• 10:11
  Speaker 4: founder's effect there, but it's spread all across the United States,
• 10:18
  Speaker 4: and it's you know, it is terrible on the locations
• 10:21
  Speaker 4: you mentioned, but it's also terrible on other locations people
• 10:25
  Speaker 4: may not always think of. And so you know, you
• 10:27
  Speaker 4: have San Francisco, certain parts of it, and it's growing
• 10:31
  Speaker 4: in San Francisco, and you have like Seattle. So yeah,
• 10:36
  Speaker 4: it's it's it's growing quicker than it's like being improved.
• 10:41
  Speaker 1: So you know, it's really interesting.
• 10:43
  Speaker 4: Uh.
• 10:43
  Speaker 2: You know, when I was in high school, I was
• 10:46
  Speaker 2: I did a study on drug addicted babies, babies who
• 10:51
  Speaker 2: moms or addicted to drugs, and they came out they
• 10:54
  Speaker 2: were addicted to drugs. So yes, that is you know,
• 10:58
  Speaker 2: that was one of the most emotional moments in my
• 11:00
  Speaker 2: young life to see that I'm helpless. I can't do
• 11:04
  Speaker 2: anything about this, you know, you know, because the problem
• 11:06
  Speaker 2: started before the child was even born. And so and
• 11:10
  Speaker 2: then you look at this side of the table, can
• 11:13
  Speaker 2: you tell me what exactly is opioid?
• 11:18
  Speaker 4: So yeah, So an opioid is you know, it's a
• 11:22
  Speaker 4: class of chemicals naturally occurring and a flower called like
• 11:26
  Speaker 4: the opium poppy, and it's been used for hundreds of
• 11:30
  Speaker 4: years for pain control, but it also is like very
• 11:35
  Speaker 4: addictive and like the modern forms of kind of the
• 11:39
  Speaker 4: opioid compound have been refined to the point where they
• 11:45
  Speaker 4: bind to the like pain control and like pleasure receptor
• 11:49
  Speaker 4: of the brain very very like strongly. And so when
• 11:55
  Speaker 4: patients stop taking the opioids, which you know now are
• 12:00
  Speaker 4: often required illicitly and have like sentinel and super dangerous things.
• 12:05
  Speaker 4: So yet when they stop taking it, they go into
• 12:06
  Speaker 4: it the withdrawal and they have a very painful food
• 12:10
  Speaker 4: like illness but way worse than the flu, you know
• 12:12
  Speaker 4: that last days usually and so yeah, that compels them
• 12:18
  Speaker 4: to keep using the opioid because they don't want to
• 12:20
  Speaker 4: go through that experience. And then you know, as their
• 12:23
  Speaker 4: brain gets used to the opioid to help, the will
• 12:25
  Speaker 4: require higher and higher doses, and eventually they will requires
• 12:29
  Speaker 4: such a high dose that the overdose potentially fatal overdose.
• 12:34
  Speaker 2: Well, you mentioned the drug in there, fentanyl, because I've
• 12:38
  Speaker 2: heard that drug tied to opiod. Please explain to my
• 12:42
  Speaker 2: audience into me. Why do does the word fentanyl pop
• 12:46
  Speaker 2: up a lot when you hear opioid use.
• 12:49
  Speaker 4: So Fentol's driving by and large, like the vast majority
• 12:54
  Speaker 4: of deaths related to like drug use currently in the
• 12:57
  Speaker 4: United States, like old fashioned opioids like heroin are actually
• 13:03
  Speaker 4: pretty rare. Now, centinels is very easy to produce, like
• 13:09
  Speaker 4: and like home home laboratories, and you only need like
• 13:14
  Speaker 4: a few grains of sand of it, like in the
• 13:17
  Speaker 4: thing you're selling in order to you know, satisfy the
• 13:21
  Speaker 4: person who's trying to wow. Are these opioids and if
• 13:25
  Speaker 4: you take one or two extra grains of sand and
• 13:28
  Speaker 4: you could potentially die?
• 13:30
  Speaker 1: Is that toxic?
• 13:33
  Speaker 4: Is that toxic?
• 13:33
  Speaker 1: Yeah?
• 13:34
  Speaker 4: It's like the doses micrograms versus like milligrams for like
• 13:38
  Speaker 4: something like morphine.
• 13:41
  Speaker 1: Wow, yeah, you.
• 13:42
  Speaker 2: Know, you know I first of all, you're doing a great,
• 13:45
  Speaker 2: great cause, but also you know, as an entrepreneur, you
• 13:49
  Speaker 2: know this is this is a show about entrepreneurship. This
• 13:51
  Speaker 2: is about you know, being able to take an idea
• 13:54
  Speaker 2: and turn it into a concert and then validate that
• 13:57
  Speaker 2: by turning it into a business model. Now with that
• 14:01
  Speaker 2: being a business model, because we want to continue to
• 14:03
  Speaker 2: talk about this, because I want to talk about the
• 14:04
  Speaker 2: use and you know, the care and all that process.
• 14:08
  Speaker 2: But it just always amazes me when individuals and I
• 14:11
  Speaker 2: have to use the word visionary when I talk to
• 14:13
  Speaker 2: you because I would have never thought about this. That's
• 14:15
  Speaker 2: why I mentioned to you about my association with drug
• 14:19
  Speaker 2: addicted babies when I was a senior in high school.
• 14:21
  Speaker 2: So I've always had this, this this emotional, carying side
• 14:27
  Speaker 2: of me. How can we stop this? How can we
• 14:29
  Speaker 2: fix this?
• 14:30
  Speaker 4: Now?
• 14:30
  Speaker 2: I know my situation is different yours, because yours is
• 14:33
  Speaker 2: about you know, OPI ard use disorder, care a methadon't
• 14:36
  Speaker 2: they have They have a drug out there that can
• 14:39
  Speaker 2: assist them, and living a normal life is about how
• 14:42
  Speaker 2: they are receiving it, and you're stopping that point of
• 14:46
  Speaker 2: having to come into an office. And I'm sure the
• 14:50
  Speaker 2: doctors like that because that doesn't slow them down. The
• 14:52
  Speaker 2: nurses like that doesn't slow them down as well.
• 14:54
  Speaker 4: Correct, right, Yeah, So they reduced clinic foot traffic when
• 15:01
  Speaker 4: there's a lot of patients on scenario, and then you
• 15:03
  Speaker 4: have improved patient retention and so like from a revenue
• 15:07
  Speaker 4: perspective for our customers, the longer patients and treatment and
• 15:11
  Speaker 4: more revenue the customer makes. So my reducing dropout we
• 15:15
  Speaker 4: kind of help customers keep their revenue life cool.
• 15:20
  Speaker 2: Al do you want to we have to go to
• 15:21
  Speaker 2: break right quick, Dr Giles, if anyone wants to call in,
• 15:25
  Speaker 2: because I know the nature of this may have some questions,
• 15:27
  Speaker 2: may have some family members that you may want to
• 15:29
  Speaker 2: understand how they can gain use of this. We're going
• 15:32
  Speaker 2: to find out exactly in the different locations that this
• 15:34
  Speaker 2: is available, how it can be available as a virtual process,
• 15:38
  Speaker 2: and that has to be understood as well. When we
• 15:40
  Speaker 2: return more with money Making Conversations master class with doctor
• 15:43
  Speaker 2: Michael Giles and his process of being able to help
• 15:47
  Speaker 2: people with opioid use disorder.
• 15:51
  Speaker 3: Please don't go anywhere, We'll be right back with more
• 15:54
  Speaker 3: money Making Conversations Masterclass. Welcome back to the Money Making
• 16:05
  Speaker 3: Conversations Masterclass, hosted by Rashaan McDonald. Money Making Conversations Masterclass
• 16:11
  Speaker 3: continues online at Moneymakingconversations dot com and follow money Making
• 16:16
  Speaker 3: Conversations Masterclass on Facebook, Twitter, and Instagram.
• 16:20
  Speaker 2: My guest is doctor Michael Giles. He's inventive there. He's
• 16:24
  Speaker 2: invented created a methadone treatment program that's virtual, which allows
• 16:29
  Speaker 2: individuals who are going through these programs not having to
• 16:32
  Speaker 2: go into a doctor's office. But it's an honor system.
• 16:35
  Speaker 2: When they take the drug, they videotape themselves and it
• 16:38
  Speaker 2: gets logged in am I am I shorthanding it correctly
• 16:42
  Speaker 2: there at doctor Giles.
• 16:44
  Speaker 4: Yeah, Well, without scenario, it's an honor system. So without
• 16:48
  Speaker 4: scenario you get take homes and the provider doesn't really
• 16:51
  Speaker 4: know if you're taking them or not. Right with scenario,
• 16:56
  Speaker 4: you know for sure whether the patient's taking their medication.
• 16:59
  Speaker 2: Cool, Now, how does that's a scenario that's the name
• 17:01
  Speaker 2: of the clinic, say clinic scenario health clinic.
• 17:06
  Speaker 4: Our application okay o health out the clinic?
• 17:09
  Speaker 2: How do they ensure the security and privacy of patient data?
• 17:11
  Speaker 2: And uh, what measures in place? To comply with these
• 17:14
  Speaker 2: regulatory requirements, because that's the number one fear I would have,
• 17:17
  Speaker 2: you know, Yeah, you know I always read about somebody
• 17:20
  Speaker 2: holding somebody ransom or breaking into How are you protecting
• 17:24
  Speaker 2: the patient's data?
• 17:26
  Speaker 4: Yes, so we have a healthcare contract with Google healthcare platform.
• 17:32
  Speaker 4: So you know, in order for that platform to be legal,
• 17:35
  Speaker 4: like Google can't access that data, I can't access that data.
• 17:40
  Speaker 4: Only the treatment team like techno, technical support team and
• 17:44
  Speaker 4: scenario and the patient have access to that data. And
• 17:47
  Speaker 4: that data is never used for ads or any other
• 17:50
  Speaker 4: commercial purposes. It's exclusively to you for treatment planning.
• 17:55
  Speaker 2: That's important to know that your information is suddenly appearing
• 17:58
  Speaker 2: on some a million list and they send you concert
• 18:01
  Speaker 2: tickets and pizza coupons and things like that. This stuff
• 18:05
  Speaker 2: is locked in. It is used strictly for their patient
• 18:08
  Speaker 2: care and not distributed. Like you said, Google doesn't gain access.
• 18:12
  Speaker 2: You don't gain any personal access to this. No one
• 18:14
  Speaker 2: gains access to this. This is strictly for the health
• 18:17
  Speaker 2: care patient, the patient's knowledge in their format.
• 18:20
  Speaker 4: Correct exactly, the patient and the survivor.
• 18:23
  Speaker 1: You know, we talked about this a little earlier.
• 18:25
  Speaker 2: You said, you know, basically the doctors are they feel
• 18:28
  Speaker 2: very comfortable and happy about this process nor health system?
• 18:32
  Speaker 2: And then the patients they're the key. How are how
• 18:35
  Speaker 2: do you recruit your patients? How do they find out
• 18:38
  Speaker 2: about your health system? And and how do they respond
• 18:42
  Speaker 2: to it?
• 18:44
  Speaker 4: Oh man, the patients respond so well because you know,
• 18:48
  Speaker 4: the typical patients story is, you know, I've been going
• 18:52
  Speaker 4: to the clinic for months to years and I only
• 18:55
  Speaker 4: have two or three take on us as a week,
• 18:57
  Speaker 4: and then all of a sudden, I get put on
• 18:58
  Speaker 4: SNARIO and I have you know, six or thirteen take
• 19:02
  Speaker 4: home doses and so like you know, as a patient,
• 19:05
  Speaker 4: I can now look for an apartment or get a job.
• 19:08
  Speaker 4: It's pretty life changing. And in places like you know,
• 19:12
  Speaker 4: Alaska where the patient is driving like two hours one
• 19:16
  Speaker 4: way to the clinic, I mean, it's literally like the
• 19:19
  Speaker 4: most kind of freedom enhancing moment that these patients have
• 19:23
  Speaker 4: had in a long time. So patients love it. And
• 19:26
  Speaker 4: in terms of like how we choose which patients get
• 19:29
  Speaker 4: put on it, So when we're implementing at a clinic,
• 19:33
  Speaker 4: we work with the clinical team there to kind of
• 19:37
  Speaker 4: draft new clinical criteria for who should be given scenario.
• 19:43
  Speaker 4: And you know how quickly they should be getting take homes.
• 19:47
  Speaker 4: And on average, you know, patients on scenario with the
• 19:50
  Speaker 4: schedules that we created, these clinics have twice a number
• 19:54
  Speaker 4: of take homes compared to a patient who's been on
• 19:57
  Speaker 4: Sonaria or sorry, who hasn't been on Sinnaro.
• 20:01
  Speaker 2: Scenario. The name, how did you come up with the name?
• 20:04
  Speaker 2: And why I tied to this particular process Scenara.
• 20:09
  Speaker 4: I mean, we were brainstorming names and someone in our company,
• 20:15
  Speaker 4: you know, who speaks Spanish, said the word to dream
• 20:19
  Speaker 4: like the future tense to dream is the word Sonyata,
• 20:23
  Speaker 4: and I thought that was a really cool name. You know,
• 20:26
  Speaker 4: you want patients to dream of like a future where
• 20:28
  Speaker 4: they're there for you, So it just seemed very fitting.
• 20:32
  Speaker 1: It's powerful.
• 20:33
  Speaker 2: It's not only fitting, but it's powerful because you know,
• 20:36
  Speaker 2: because this is the educational part to me, because you
• 20:39
  Speaker 2: you you going through life and somehow OPR falls into
• 20:44
  Speaker 2: your life and you, uh, they call it OPR use
• 20:47
  Speaker 2: this or the o U D you commit to a
• 20:50
  Speaker 2: methadone treatment program? Do you ever get off the program?
• 20:54
  Speaker 2: Doctor Jiles?
• 20:57
  Speaker 4: Yes, that's what the patient's goals are. So I wish
• 21:01
  Speaker 4: we were at at a point where that was like
• 21:03
  Speaker 4: the focus, but right now, like most patients drop out
• 21:07
  Speaker 4: of treatment was in the first sixty days, and you know,
• 21:12
  Speaker 4: as soon as that happens, the risk of like having
• 21:14
  Speaker 4: a fatal overdose increases by nearly three hundred percent. And
• 21:18
  Speaker 4: so you know, the minimum amount of treatment time for
• 21:22
  Speaker 4: the American Society of Addiction Medicine is one year. So
• 21:26
  Speaker 4: when we can start getting most patients to one year,
• 21:29
  Speaker 4: I really want to start thinking about answering the question
• 21:32
  Speaker 4: you mentioned, like how do we taper patients off? And
• 21:36
  Speaker 4: you know, eventually they don't need anything, But until we
• 21:40
  Speaker 4: can solve this kind of crisis in the first sixty days,
• 21:44
  Speaker 4: we just don't have a bandwage to solve that other
• 21:46
  Speaker 4: thing right now?
• 21:48
  Speaker 2: Wow, Because you know, it's like how do you get
• 21:52
  Speaker 2: your life back if it's still tied to a treatment program?
• 21:55
  Speaker 2: You know, how do you gain confidence, how do you
• 21:58
  Speaker 2: have a relationship, how do you how do you do anything?
• 22:01
  Speaker 2: How do you move on?
• 22:02
  Speaker 1: You know, with this.
• 22:03
  Speaker 2: Treatment program, it seems like it's forever going on. You
• 22:06
  Speaker 2: know now it always tied to anything. You know, just
• 22:08
  Speaker 2: because there's a program out there, you have to have
• 22:10
  Speaker 2: eligibility with criteria tied to it, Sonario, what are the
• 22:14
  Speaker 2: eligibility criteria and also again this is a virtual process,
• 22:17
  Speaker 2: and before you talk about eligibility criteria, tell them again
• 22:20
  Speaker 2: how it works, doctor Giles.
• 22:24
  Speaker 4: Yeah, So the way the application works is patients will
• 22:27
  Speaker 4: get their take home methidena. It'll have a special label
• 22:31
  Speaker 4: on the bottle and you know there's one dose per
• 22:35
  Speaker 4: bottle and you just use one bottle per day. And
• 22:37
  Speaker 4: so you're at home with all these bottles and you know,
• 22:40
  Speaker 4: you log into snarti app and you press to take
• 22:43
  Speaker 4: my dose button and says then it'll ask you scan
• 22:46
  Speaker 4: the QR code on the methodone bottle. So you'll scan
• 22:50
  Speaker 4: it and then it'll you know, we'll confirm that that
• 22:53
  Speaker 4: bottle has never been scanned or used before. And then
• 22:57
  Speaker 4: it'll flip to the front facing camera and you know,
• 23:00
  Speaker 4: we give the patient self une stands and so the
• 23:02
  Speaker 4: patient will put the cell phone on the self unstand
• 23:05
  Speaker 4: and they'll open the bottle and take the medication. And
• 23:09
  Speaker 4: so you know that whole process takes about seventy two
• 23:12
  Speaker 4: seconds on average across the hundreds of thousands of doses
• 23:15
  Speaker 4: be recorded. You compare that seventy two seconds two hours
• 23:19
  Speaker 4: of your day if you're not using scenario wow, trying
• 23:22
  Speaker 4: to go to the clinic.
• 23:23
  Speaker 2: That's the process. So how does one as a patient
• 23:27
  Speaker 2: qualify or what is the criteria to qualify for the
• 23:32
  Speaker 2: use of this type of scenario health solution?
• 23:37
  Speaker 4: Now that is a much more complicated question unfortunately. So
• 23:41
  Speaker 4: like macedone is probably the most regulated medication in the
• 23:45
  Speaker 4: United States, and every state has their own rules for
• 23:50
  Speaker 4: how methadone can be prescribed, so it really will vary
• 23:55
  Speaker 4: from state to state. And then on top of that,
• 23:58
  Speaker 4: every clinic has their own culture and you know, our job,
• 24:02
  Speaker 4: it's scenarios to try to make clinics have the most
• 24:05
  Speaker 4: patient centered culture possible. But the best answer to that
• 24:10
  Speaker 4: question are really going to depend on where the patients live.
• 24:12
  Speaker 4: But you have some common factors though, like you're on
• 24:16
  Speaker 4: a stable dose in methodone, so you're not needing to
• 24:18
  Speaker 4: go up and down all the time in your dose wow.
• 24:23
  Speaker 4: You know, attendance hasn't been too much of an issue,
• 24:26
  Speaker 4: you know, conversly, right, if the attendance is an issue,
• 24:28
  Speaker 4: maybe you need sonarto, right, So just it really it
• 24:31
  Speaker 4: really depends on kind of the clinics.
• 24:34
  Speaker 2: Well, you know, the things about you're based in Houston, Texas. Correct, Dallas, Dallas.
• 24:39
  Speaker 2: Text You're based in Dallas, Texas. Apologize Scenari Health Solutions. Now,
• 24:43
  Speaker 2: what's the future? You know, you got it rolling. We
• 24:46
  Speaker 2: know this is a business as you know, entrepreneurship kicked in,
• 24:52
  Speaker 2: but it's also helping people get their lives back. What
• 24:56
  Speaker 2: is in product development or outreach program?
• 24:59
  Speaker 1: What do you have? What's that's the next step for
• 25:00
  Speaker 1: son Our Health Solutions.
• 25:03
  Speaker 4: Yeah, so right now our application is really centered on
• 25:07
  Speaker 4: kind of this virtual dosing window experience, you know, recreating
• 25:11
  Speaker 4: the in person dosing but like more conveniently even your
• 25:14
  Speaker 4: cell phone at your home. We want to expand that
• 25:18
  Speaker 4: to be more broadly just patient engagement, specifically the kind
• 25:23
  Speaker 4: of answer one of the questions you asked earlier, like
• 25:25
  Speaker 4: how does the picture come off the system? Right, So,
• 25:27
  Speaker 4: we don't want the patient to have to record every
• 25:30
  Speaker 4: day if they're clinically stable. It's intrusive and not nice,
• 25:34
  Speaker 4: and so we'll just have kind of more generally useful
• 25:38
  Speaker 4: patient engagement tools like messaging, counseling sessions, virtual intakes, things
• 25:45
  Speaker 4: like that. So that's kind of the future of our product.
• 25:48
  Speaker 2: Well, you know, some doctor Giles I'm proud of you,
• 25:50
  Speaker 2: my man. You know, I say that because not many people.
• 25:57
  Speaker 2: You know, there are people out there making money off
• 25:59
  Speaker 2: of car and making making money off of Hamburgers, and
• 26:03
  Speaker 2: businesses set up and these are fantastic. There are not
• 26:06
  Speaker 2: many businesses that are set up to save people's lives
• 26:10
  Speaker 2: and change communities. And that's what you're doing. You know,
• 26:14
  Speaker 2: if nobody's saying that to you, let me say that
• 26:16
  Speaker 2: to you. Because the fact that I was in the
• 26:19
  Speaker 2: hospital for thirty days one time in my life, and
• 26:22
  Speaker 2: they had a drug attached to me because I was
• 26:24
  Speaker 2: in so much pain. I would press a button and now,
• 26:28
  Speaker 2: after a while, the drug will stop entering my system.
• 26:30
  Speaker 2: But I kept pressing that button because they knew if
• 26:33
  Speaker 2: I just kept pressing that button, I would become addicted
• 26:35
  Speaker 2: to that drug. So eventually I had to learn to
• 26:37
  Speaker 2: live with the pain, and eventually I got off of
• 26:40
  Speaker 2: They weaned me off of that machine. So I know
• 26:43
  Speaker 2: what addiction can feel like. I know the impact of
• 26:47
  Speaker 2: that machine not being and managed correctly, how I could
• 26:51
  Speaker 2: have impacted my life today. But I brought you on
• 26:54
  Speaker 2: this show. You know, you're a different type of entrepreneur.
• 26:57
  Speaker 2: I brought on this show, but I thought it was
• 26:58
  Speaker 2: necessary for people to hear here that there are many
• 27:01
  Speaker 2: ways people out there being entrepreneurs, changing people's lives and
• 27:05
  Speaker 2: being a positive force in the community. And that's what
• 27:08
  Speaker 2: you are, my brother, and I always know I'm I'm
• 27:11
  Speaker 2: a fan and uh as I always say my show,
• 27:14
  Speaker 2: I close it out with the word keep winning. I'm
• 27:16
  Speaker 2: gonna tell you, my friend, keep winning as we close
• 27:18
  Speaker 2: it is any contact information you want to share.
• 27:20
  Speaker 4: With my audience, Yeah, you know, anyone's interested in sonar,
• 27:26
  Speaker 4: I feel free to email Phil Phil at Scenari Health
• 27:32
  Speaker 4: dot com and you will reach it back out to you.
• 27:36
  Speaker 1: Cool.
• 27:36
  Speaker 2: Thank you, my friend for taking the time to come
• 27:37
  Speaker 2: on Money Making Conversation master Class.
• 27:39
  Speaker 1: Stay safe, okay to thank you Rashan.
• 27:43
  Speaker 2: This has been another edition of Money Making Conversation Masterclass
• 27:47
  Speaker 2: posted by me Rashawn McDonald. Thank you to our guests
• 27:50
  Speaker 2: on the show today and thank you. I'll listen to
• 27:52
  Speaker 2: the audience now. If you want to listen to any
• 27:54
  Speaker 2: episode I want to be a guest on the show,
• 27:57
  Speaker 2: visit Moneymakingconversations dot com should be the handle is money
• 28:01
  Speaker 2: Making Conversation. Join us next week and remember to always.
• 28:04
  Speaker 1: Leave with your gifts keep winning.
• 28:07
  Speaker 4: Mm hmm